Intelligent Bio Solutions Inc. (NASDAQ:INBS – Get Rating) – Equities researchers at Zacks Small Cap issued their Q4 2023 earnings per share (EPS) estimates for Intelligent Bio Solutions in a note issued to investors on Monday, June 5th. Zacks Small Cap analyst J. Vandermosten anticipates that the company will earn ($1.66) per share for the […]
PROCEPT BioRobotics (NASDAQ:PRCT – Get Rating) and Intelligent Bio Solutions (NASDAQ:INBS – Get Rating) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, risk, institutional ownership, earnings, analyst recommendations, valuation and dividends. Institutional and Insider Ownership 66.4% of PROCEPT BioRobotics […]
11.05.2023 - - Combined revenue and government support income increased 199% year-over-year - - Sequential revenue growth of 28% Filed 513(g) submission with U.S. FDA for Intelligent Fingerprinting Drug Screening Cartridge - - Granted U.K. patent relating .
Intelligent Bio Solutions (NASDAQ:INBS – Get Rating) and Regenicin (OTCMKTS:RGIN – Get Rating) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, analyst recommendations, institutional ownership, valuation, risk and profitability. Insider & Institutional Ownership 2.3% of Intelligent Bio Solutions […]
Regenicin (OTCMKTS:RGIN – Get Rating) and Intelligent Bio Solutions (NASDAQ:INBS – Get Rating) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, institutional ownership, profitability, earnings, analyst recommendations, valuation and risk. Insider & Institutional Ownership 2.3% of Intelligent Bio Solutions […]